Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3841 AL 3855

Applications of Nanoparticles in Alzheimer's Disease

Liu Y, Shen Y.

J Alzheimers Dis. 2023;96(2):459-471. doi: 10.3233/JAD-230098.

Alterations of Audiovisual Integration in Alzheimer's Disease

Liu Y, Wang Z, Wei T, Zhou S, Yin Y, Mi Y, Liu X, Tang Y.

Neurosci Bull. 2023 Dec;39(12):1859-1872. doi: 10.1007/s12264-023-01125-7. Epub 2023 Oct 9.

Letter to Our Colleagues Family Practitioners, Geriatricians, and Radiologists to Increase Awareness Regarding Idiopathic Normal Pressure Hydrocephalus

Rigamonti D, Yasar S, Vivas-Buitrago T, Rigamonti K.

World Neurosurg. 2024 Jan;181:e291-e293. doi: 10.1016/j.wneu.2023.10.040. Epub 2023 Oct 12.

Case Study 6: The Diagnostic Challenge of a 75-Year-Old Man Who Had, Then Didn't Have, Then Did Have Alzheimer's Disease

Ramírez-Salazar SA, MacRae C, Feany MB, Miller M, Yang HS, Meadows ME, McGinnis SM, Silbersweig D, Gale SA, Daffner KR.

J Neuropsychiatry Clin Neurosci. 2023 Fall;35(4):325-332. doi: 10.1176/appi.neuropsych.20230097.

The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm

Dublin S, Greenwood-Hickman MA, Karliner L, Hsu C, Coley RY, Colemon L, Carrasco A, King D, Grace A, Lee SJ, Walsh JME, Barrett T, Broussard J, Singh U, Idu A, Yaffe K, Boustani M, Barnes DE.

Contemp Clin Trials. 2023 Dec;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17.

An imaging review of the hippocampus and its common pathologies

Lang M, Colby S, Ashby-Padial C, Bapna M, Jaimes C, Rincon SP, Buch K.

J Neuroimaging. 2024 Jan-Feb;34(1):5-25. doi: 10.1111/jon.13165. Epub 2023 Oct 23.

Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease

Cohen S, van Dyck CH, Gee M, Doherty T, Kanekiyo M, Dhadda S, Li D, Hersch S, Irizarry M, Kramer LD.

J Prev Alzheimers Dis. 2023;10(4):771-777. doi: 10.14283/jpad.2023.123.

Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia

Yassine HN, Arellanes IC, Mazmanian A, De La Cruz L, Martinez J, Contreras L, Kono N, Liu BS, Badie D, Bantugan MA, Grindon A, Urich T, D'Orazio L, Emmanuel BA, Chui HC, Mack WJ, Harrington MG, Braskie MN, Schneider LS.

J Prev Alzheimers Dis. 2023;10(4):810-820. doi: 10.14283/jpad.2023.77.

Perceptions, beliefs, attitudes, and knowledge of US Latino adults pertaining to dementia and brain health: a systematic review

Light SW, Tomasino F, Wescott A, Bernstein Sideman A, Vela A, Possin KL, Penedo FJ, Wolf MS.

Aging Ment Health. 2024 Mar-Apr;28(3):396-407. doi: 10.1080/13607863.2023.2268050. Epub 2023 Oct 24.

Neuropsychiatric symptoms as a prodromal factor in Alzheimer's type neurodegenerative disease: A scoping review

Ferreira DA, Macedo LBC, Foss MP.

Clin Neuropsychol. 2024 Jul;38(5):1031-1059. doi: 10.1080/13854046.2023.2273574. Epub 2023 Oct 26.

Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer's Disease

Yang Y, Bagyinszky E, An SSA.

Int J Mol Sci. 2023 Oct 23;24(20):15461. doi: 10.3390/ijms242015461.

Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment

Cozza M, Amadori L, Boccardi V.

J Neurol Sci. 2023 Nov 15;454:120866. doi: 10.1016/j.jns.2023.120866. Epub 2023 Nov 2.

Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease

Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group.

N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430.

Early Hippocampal Atrophy Is an Important Signal for Clinicians but Not Necessarily a Harbinger of Alzheimer Disease

Nelson PT, Jicha GA.

Neurology. 2023 Dec 12;101(24):1087-1088. doi: 10.1212/WNL.0000000000208071. Epub 2023 Nov 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias